Author: healthprofessionalradio

Tracy Curley, the CEO of iSpecimen, an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, discusses the iSpecimen platform, the importance of just-in-time biobanking and what’s up next for the industry. 

Dr. Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s pegozafermin in patients with severe hypertriglyceridemia (SHTG) that was published online in “Nature Medicine” (June 24, 2023). To learn more about pegozafermin’s indications in non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG), please visit https://www.89bio.com/pipeline/.

Dr. Comilla Sasson, MD, PhD, Vice President for Healthcare Business Solutions at the American Heart Association and a practicing Emergency Medicine physician in Denver, Colorado discusses AHA’s newly launched Nation of Lifesavers™ initiative to double survival rates from sudden cardiac arrest by 2030. The new multi-year initiative will ensure teens and adults can learn about CPR and AED use, share that knowledge with friends and family and engage employers, policymakers, philanthropists, and others to create support for a nation of lifesavers. She talks about the do’s and don’ts of CPR, including some common misconceptions, and shares some familiar songs from a variety of genres that can help everyone easily keep the correct pace when performing CPR

Dr. Erin Crane, MD, MPH, gynecologic oncologist  with the Atrium Health Levine Cancer Institute and Bobbie, an ovarian cancer patient discuss the prevalence of ovarian cancer, risk factors, the importance of biomarker testing, the diagnosis journey, and important questions to ask after diagnosis.

Claude Royster, VP and GM of Healthcare Select Specialties, Health & Wellness at Synchrony discusses recent research revealing that more than one-third of orthopedists are experiencing burnout, the factors contributing to orthopedist burnout, and the impact on patients. He talks about the use of new financial technologies in healthcare, and how Synchrony can help streamline financial processes in the doctor’s office.

Vin Singh, Founder and CEO of BullFrog AI, a precision medicine company, discusses their bfLEAP Platform and how leveraging the power of AI and machine learning can quickly digest and analyze large sets of data and reveal insights about treatment response against patient populations which will improve selection for clinical trials and boost success rates.

Mary Beth Cicero, CEO ​and co-founder of 3Daughters discusses the development of the company’s lead product candidate, a frameless self-assembling intrauterine device (IUD) therapy for contraception. Unlike the T-shaped IUDs currently on the market, the 3Daughters team is combining physics and geometry to form a copper-made triangular magnetic-shaped IUD that self-forms in a woman’s uterus. This allows for women to have a simpler, smart, and more sophisticated alternative to birth control. The Company’s proprietary Glider™ for insertion (i-Glider) is far less painful and a simple magnetic retriever (r-Glider) completes the cycle – no strings needed.​

Colleen Acosta, CEO and Co-Founder of Freya Biosciences, a biotech company dedicated to advancing women’s reproductive health discusses the critical needs facing women’s healthcare and the complexities of reproductive health for families and individuals worldwide. She talks about what it means to be a female leader in bioscience, the significance of her leadership role, the broader responsibilities that go along with it, and the experiences that led her to where she is now.

Richard T. Lee, MD, Cherng Family Director’s Chair, Center for Integrative Oncology at City of Hope, one of the largest cancer research and treatment organizations in the United States, discusses his oral presentation at the Society for Integrative Oncology International Conference titled “Reasons and Types of Medical Cannabis (MC) Use by Patients with Cancer Receiving Treatment at a Comprehensive Cancer Center (CCC).” He talks about a $100 million gift from the founders of Panda Express to create a first-of-its-kind, national integrative oncology program that brings together Eastern and Western medicine for cancer patients. Lee is the first researcher in the country to receive funding from the National Cancer Institute to conduct a clinical trial studying the effects of cannabidiol (CBD) and tetrahydrocannabinol (THC), the chemical compounds in cannabis, for the treatment of chronic chemotherapy-induced peripheral neuropathy, a common nerve-damaging side effect of treatment.

Dr. John Laird, MD, Chief Medical Officer for Peripheral Vascular Health at Medtronic, and Terry Litchfield, President of Access Solutions and a patient advocate discuss a new national survey conducted by the National Kidney Foundation (NKF) in partnership with Medtronic that has uncovered a potential gap in awareness for end-stage kidney disease (ESKD) patients undergoing hemodialysis when it comes to awareness about minimally invasive options for hemodialysis access point creation. They talk about the impact that knowledge and choice have on dialysis patients and their care partners and offer insights into the benefits of options available outside of surgery for eligible ESKD patients.